IMMUTIL-S 360

Immutil S 360 tablet is an immunosuppressant that contains Mycophenolate sodium as its active ingredient. It falls under the category of inosine monophosphate dehydrogenase (IMPDH) inhibitors. This medication is utilized to prevent organ rejection in patients who have undergone organ transplants, such as kidney, heart, or liver transplants. It is typically prescribed as part of a combination therapy alongside other immunosuppressive agents.

This medication is contraindicated during pregnancy due to the potential for birth defects and miscarriage. It should only be recommended to pregnant women if there are no suitable alternatives and the benefits significantly outweigh the risks. Female patients of childbearing age are strongly advised to use effective contraception while taking this tablet to avoid pregnancy. Live vaccines should not be given to individuals taking Immutil S 360 tablets, as this can lead to decreased vaccine efficacy and an increased risk of infection. Patients on this medication should refrain from donating blood during treatment and for at least six weeks after discontinuation to ensure that the drug has been sufficiently eliminated from the body before blood donation.

It is generally recommended to avoid this medication if you have an allergy to it or any of its components. Notify your healthcare provider if you have a history of liver or heart disease prior to starting treatment. Since this drug suppresses the immune system, it may elevate the risk of skin cancer. Patients should take measures to minimize their exposure to sunlight and ultraviolet (UV) light. Contact your doctor immediately if you experience any bruising, fever, unexplained fatigue, dizziness, jaundice, vision changes, decreased urine output, or seizures after taking this medication. Immutil S 360 tablet is an immunosuppressive drug that may impact the developing immune system of an infant and should be avoided during breastfeeding.